Caristo Diagnostics, the medical imaging company, has completed a multi-million-pound investment round. The round was led by BGF, the UK’s most active growth economy investor, and existing investors including Oxford Sciences Innovation (OSI), Longwall Ventures and the Oxford Technology & Innovation Fund (OTIF).

The funding will be used to roll-out Caristo Diagnostic’s CaRi-Heart^®, a ground-breaking AI-based cardiovascular risk prediction technology, which has just received its CE mark accreditation and is available for use by doctors across the UK and Europe.